Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Antidepressants and breast and ovarian cancer risk: a review of the literature and researchers' financial associations with industry.

Cosgrove L, Shi L, Creasey DE, Anaya-McKivergan M, Myers JA, Huybrechts KF.

PLoS One. 2011 Apr 6;6(4):e18210. doi: 10.1371/journal.pone.0018210. Review.

2.

Use of antidepressants and the risk of breast cancer: a meta-analysis.

Eom CS, Park SM, Cho KH.

Breast Cancer Res Treat. 2012 Dec;136(3):635-45. doi: 10.1007/s10549-012-2307-y. Epub 2012 Nov 9.

PMID:
23139055
3.

Antidepressant medication use [corrected] and risk of ovarian cancer.

Moorman PG, Berchuck A, Calingaert B, Halabi S, Schildkraut JM.

Obstet Gynecol. 2005 Apr;105(4):725-30. Erratum in: Obstet Gynecol. 2005 Jun;105(6):1495.

PMID:
15802397
4.

Newer generation antidepressants for depressive disorders in children and adolescents.

Hetrick SE, McKenzie JE, Cox GR, Simmons MB, Merry SN.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD004851. doi: 10.1002/14651858.CD004851.pub3. Review.

PMID:
23152227
5.

Health-related quality of life in early breast cancer.

Groenvold M.

Dan Med Bull. 2010 Sep;57(9):B4184.

PMID:
20816024
6.

Systematic review of the epidemiologic and trial evidence of an association between antidepressant medication and breast cancer.

Lawlor DA, Jüni P, Ebrahim S, Egger M.

J Clin Epidemiol. 2003 Feb;56(2):155-63. Review.

PMID:
12654410
7.

Hormone replacement therapy and cancer.

[No authors listed]

Gynecol Endocrinol. 2001 Dec;15(6):453-65. Review.

PMID:
11826770
8.

Metformin and breast cancer risk: a meta-analysis and critical literature review.

Col NF, Ochs L, Springmann V, Aragaki AK, Chlebowski RT.

Breast Cancer Res Treat. 2012 Oct;135(3):639-46. doi: 10.1007/s10549-012-2170-x. Epub 2012 Jul 31. Review.

PMID:
22847511
9.

Breast cancer risk among users of antidepressant medications.

González-Pérez A, García Rodríguez LA.

Epidemiology. 2005 Jan;16(1):101-5.

PMID:
15613952
10.

Patients' views on financial conflicts of interest in cancer research trials.

Hampson LA, Agrawal M, Joffe S, Gross CP, Verter J, Emanuel EJ.

N Engl J Med. 2006 Nov 30;355(22):2330-7.

11.

Optimal primary surgical treatment for advanced epithelial ovarian cancer.

Elattar A, Bryant A, Winter-Roach BA, Hatem M, Naik R.

Cochrane Database Syst Rev. 2011 Aug 10;(8):CD007565. doi: 10.1002/14651858.CD007565.pub2. Review.

PMID:
21833960
12.

Antidepressant use and the risk of breast cancer: a non-association.

Wang PS, Walker AM, Tsuang MT, Orav EJ, Levin R, Avorn J.

J Clin Epidemiol. 2001 Jul;54(7):728-34.

PMID:
11438414
13.

Obesity and the risk of epithelial ovarian cancer: a systematic review and meta-analysis.

Olsen CM, Green AC, Whiteman DC, Sadeghi S, Kolahdooz F, Webb PM.

Eur J Cancer. 2007 Mar;43(4):690-709. Epub 2007 Jan 12. Review.

PMID:
17223544
14.

Antidepressant use and breast cancer risk.

Chien C, Li CI, Heckbert SR, Malone KE, Boudreau DM, Daling JR.

Breast Cancer Res Treat. 2006 Jan;95(2):131-40. Epub 2005 Dec 2.

PMID:
16322894
15.

Prophylactic mastectomy for the prevention of breast cancer.

Lostumbo L, Carbine N, Wallace J, Ezzo J.

Cochrane Database Syst Rev. 2004 Oct 18;(4):CD002748. Review. Update in: Cochrane Database Syst Rev. 2010;(11):CD002748.

PMID:
15495033
16.

Antidepressant medication use and breast cancer risk: a case-control study.

Steingart A, Cotterchio M, Kreiger N, Sloan M.

Int J Epidemiol. 2003 Dec;32(6):961-6.

PMID:
14681256
17.

Antidepressant medications and their association with invasive breast cancer and carcinoma in situ of the breast.

Moorman PG, Grubber JM, Millikan RC, Newman B.

Epidemiology. 2003 May;14(3):307-14.

PMID:
12859031
18.

Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.

Winter-Roach BA, Kitchener HC, Dickinson HO.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD004706. doi: 10.1002/14651858.CD004706.pub2. Review. Update in: Cochrane Database Syst Rev. 2009;(3):CD004706.

PMID:
19160239
19.

Soy intake and risk of endocrine-related gynaecological cancer: a meta-analysis.

Myung SK, Ju W, Choi HJ, Kim SC; Korean Meta-Analysis (KORMA) Study Group..

BJOG. 2009 Dec;116(13):1697-705. doi: 10.1111/j.1471-0528.2009.02322.x. Epub 2009 Sep 19. Review.

20.

Bisphosphonates for breast cancer.

Pavlakis N, Schmidt R, Stockler M.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003474. Review. Update in: Cochrane Database Syst Rev. 2012;2:CD003474.

PMID:
16034900

Supplemental Content

Support Center